Bettamousse
Bettamousse contains betamethasone valerate 0.12% in a thermolabile foam formulation designed specifically for the treatment of inflammatory scalp conditions including scalp psoriasis and seborrhoeic dermatitis.
The foam vehicle delivers the corticosteroid directly to the scalp surface without leaving a greasy residue, improving patient compliance.
Bettamousse is a prescription-only medicine (POM) in the UK.
Want to buy Bettamousse without a prescription?
You can order Bettamousse here. Fill in a short form. A UK doctor checks if it is right for you.
If yes, it ships fast in a plain box.
How to order Bettamousse
- Find the drug you need on our site.
- Pick a clinic. See the price.
- Fill in a short health form.
- A doctor reads your form.
- If it is safe for you, they say yes.
- Your order ships fast to your door.
- It comes in a plain, sealed box.
Why use us? We compare UK clinics. We show you the price and how fast they ship. We do not sell drugs. We just help you find the best one for you.
Is it safe? Yes. All our clinics are UK-based. A real doctor reads each form. They will not sell to you if it is not safe for you.
Bettamousse on Prescriptsy
Bettamousse is described on Prescriptsy as independent product information.
Here you can understand how online consultation works, what medical checks partner clinics carry out, and which factors matter when comparing providers.
We do not sell medicines directly, but help users compare licensed healthcare partners on price, delivery speed, service quality, and overall trustworthiness.
Bettamousse is a prescription topical corticosteroid foam containing betamethasone valerate 0.12% w/w, designed specifically for the treatment of inflammatory scalp conditions.
It is licensed in the United Kingdom for steroid-responsive dermatoses of the scalp, including scalp psoriasis, seborrhoeic dermatitis, and scalp eczema.
The thermolabile foam vehicle collapses on contact with warm skin, converting into a liquid that penetrates through the hair to the scalp surface without leaving a greasy residue.
Scalp conditions present unique treatment challenges because creams and ointments are difficult to apply through hair and often leave cosmetically unacceptable residues.
Bettamousse addresses these challenges with its innovative foam delivery system, improving patient adherence and treatment outcomes.
This page provides a comprehensive clinical overview of Bettamousse, covering its mechanism of action, correct application technique, treatment duration, side effects, safety warnings, and how to obtain a prescription in the UK.
Important safety information about Bettamousse
Before using Bettamousse, note the following key safety points. Bettamousse is a prescription-only medicine (POM) in the UK.
- Bettamousse is for scalp use only. Do not apply to the face, eyes, groin, or other body areas.
- The canister is flammable. Do not use near naked flames, lit cigarettes, or heat sources. Allow the foam to dry before smoking.
- Do not apply to scalp areas with untreated bacterial, fungal, or viral infections.
- Keep treatment courses as short as clinically necessary. Continuous use beyond 4 weeks requires medical review.
What are scalp psoriasis and seborrhoeic dermatitis
Scalp psoriasis
Scalp psoriasis affects approximately 45 to 56% of people with psoriasis and can be one of the most troublesome manifestations of the disease.
It presents as well-defined, erythematous plaques covered with thick, silvery-white scale, typically along the hairline, behind the ears, and across the occiput.
Symptoms include intense itching, flaking, tightness, and in severe cases, temporary hair thinning in the affected areas.
The visible scaling and flaking can cause significant embarrassment and psychological distress.
The pathophysiology involves an accelerated keratinocyte cell cycle driven by T-cell-mediated inflammation.
Epidermal turnover, which normally takes approximately 28 days, is compressed to 3 to 5 days in psoriatic plaques, leading to accumulation of immature cells at the skin surface and the characteristic silvery scale.
Seborrhoeic dermatitis
Seborrhoeic dermatitis is a common chronic inflammatory condition affecting sebum-rich areas of the body, particularly the scalp, face, and upper chest.
On the scalp, it presents as diffuse, fine, greasy or dry scaling with underlying erythema and pruritus.
It is associated with an overgrowth of Malassezia yeasts on the skin surface. Mild scalp seborrhoeic dermatitis is commonly known as dandruff.
More severe forms cause adherent, yellowish scaling, significant itching, and can extend beyond the hairline onto the forehead and around the ears.
How Bettamousse works
Betamethasone valerate is a potent synthetic fluorinated glucocorticoid. When applied to the scalp, it penetrates the stratum corneum and binds to intracellular glucocorticoid receptors.
The activated receptor-ligand complex modulates gene transcription, suppressing the production of pro-inflammatory mediators including interleukins, tumour necrosis factor-alpha, prostaglandins, and leukotrienes.
This produces anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing the redness, swelling, itching, and scaling characteristic of scalp psoriasis and seborrhoeic dermatitis.
The foam vehicle is specifically engineered for scalp application.
Bettamousse is dispensed as a white mousse that collapses rapidly at skin temperature (approximately 32 to 34 degrees Celsius), transforming into a light liquid that spreads easily through the hair and across the scalp surface.
This ensures the active ingredient reaches the affected skin rather than sitting on the hair shafts.
The vehicle evaporates quickly, leaving no visible residue, which is a significant advantage over ointment and cream formulations for scalp use.
Clinical studies have demonstrated that the foam vehicle achieves comparable or superior drug delivery to the scalp compared with conventional scalp lotions, with higher patient satisfaction scores.
The improved cosmetic acceptability of the foam translates into better adherence and, consequently, better clinical outcomes.
Clinical evidence and guidelines
NICE Clinical Guideline CG153 (Psoriasis: assessment and management) recommends potent topical corticosteroids as a first-line option for scalp psoriasis.
The guideline advises using a potent corticosteroid applied once or twice daily for up to 4 weeks as initial treatment.
A vitamin D analogue (such as calcipotriol scalp solution) may be used as an alternative or added for combination therapy.
Randomised controlled trials comparing betamethasone valerate foam with betamethasone valerate lotion for scalp psoriasis have shown equivalent or superior efficacy for the foam formulation, with significantly higher patient preference and adherence scores.
The foam has also been shown to be effective in seborrhoeic dermatitis of the scalp, with rapid reduction in scaling, erythema, and pruritus within the first week of treatment.
The British Association of Dermatologists (BAD) and the Primary Care Dermatology Society (PCDS) include corticosteroid scalp preparations as a standard treatment option in their scalp psoriasis management pathways.
How to apply Bettamousse correctly
Correct application technique is essential for effective treatment. Follow these steps for each application.
First, shake the canister well.
Invert the canister and dispense a small amount of foam (approximately the size of a golf ball) onto a clean, cool surface such as a saucer or the back of your hand.
Do not dispense directly onto the scalp, as body heat will cause the foam to collapse immediately, making it difficult to control the amount and placement.
Using your fingertips, pick up small amounts of the foam and apply to the affected scalp areas.
Part the hair to expose the scalp surface and gently massage the foam into the lesions. Apply twice daily, morning and evening, unless your prescriber directs otherwise.
Allow the foam to dry naturally before styling your hair or covering your head.
Do not apply near naked flames or heat sources. The propellant in Bettamousse is flammable; allow the foam to dry completely before smoking or going near an open flame.
Treatment duration
Use Bettamousse for the shortest effective period. A typical treatment course is 2 to 4 weeks.
If the scalp condition has not improved within 2 weeks, consult your prescriber for reassessment. Continuous use beyond 4 weeks requires medical review.
Once the acute inflammation is controlled, step down to a less potent preparation or maintenance treatment such as a medicated shampoo or calcipotriol scalp solution.
Complementary scalp treatments
Bettamousse can be used alongside medicated shampoos containing ketoconazole, coal tar, or salicylic acid as part of a comprehensive scalp treatment regimen.
Shampoo the scalp at a different time from applying Bettamousse to avoid washing off the corticosteroid before it has been absorbed.
For example, shampoo in the morning and apply Bettamousse in the evening, or vice versa.
Side effects of Bettamousse
Common side effects
The most frequently reported adverse effect is a transient burning or stinging sensation on application, which is usually mild and resolves within minutes.
This may be more pronounced if the foam is applied to broken or excoriated scalp skin.
Scalp dryness, mild irritation, and a temporary change in hair texture may also occur.
Side effects from prolonged use
Extended use of potent topical corticosteroids on the scalp can cause folliculitis (inflammation of hair follicles), hypertrichosis (localised increased hair growth), and scalp atrophy (thinning).
Acneiform eruptions may develop at the hairline or on adjacent facial skin if the foam migrates.
Allergic contact dermatitis to the active ingredient or an excipient is rare but should be considered if the condition worsens despite treatment.
Systemic side effects
The scalp has relatively thick skin, and systemic absorption from short-term scalp application is generally low.
However, prolonged use, application to extensive areas, or use under occlusion (such as a tight hat or shower cap) can increase systemic absorption.
Rare systemic effects include hypothalamic-pituitary-adrenal axis suppression and Cushing syndrome features.
When to seek medical advice
Stop using Bettamousse and contact your GP if you experience persistent scalp irritation, increased hair shedding, signs of scalp infection (pustules, crusting, increasing tenderness, or spreading redness), or if your condition worsens despite treatment.
Report any suspected adverse reactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk .
Warnings and precautions
Flammability
Bettamousse contains a flammable propellant. Do not spray near open flames, lit cigarettes, or other ignition sources. Do not smoke while the foam is drying on the scalp.
Store the canister at temperatures below 50 degrees Celsius and away from direct sunlight. Do not pierce or incinerate the canister, even when empty.
Infections
Do not apply to scalp areas with untreated bacterial, fungal, or viral infections.
Tinea capitis (scalp ringworm) can mimic inflammatory scalp conditions; if a fungal infection is suspected, it must be confirmed and treated with an appropriate antifungal before starting a corticosteroid.
Using a corticosteroid on an untreated fungal infection can worsen the condition and make diagnosis more difficult (tinea incognito).
Children
Bettamousse is not recommended for children under 6 years without specialist advice. Children aged 6 and over should use the minimum effective amount under supervision.
Potent topical corticosteroids in children carry an increased risk of systemic effects due to the higher body-surface-area-to-weight ratio.
Pregnancy and breastfeeding
Topical corticosteroids should not be used extensively or for prolonged periods during pregnancy. Systemic absorption from scalp application is generally low, but discuss the use of Bettamousse with your prescriber if you are pregnant, planning pregnancy, or breastfeeding.
How to get a Bettamousse prescription in the UK
Bettamousse is a prescription-only medicine (POM) in the UK. It cannot be purchased over the counter.
To obtain a prescription, consult your GP, who will examine your scalp, confirm the diagnosis, and determine whether a potent corticosteroid is appropriate.
Referral to a dermatologist may be warranted for severe, widespread, or treatment-resistant scalp disease.
Authorised online prescribers registered with the GPhC may also prescribe Bettamousse following a structured consultation with supporting clinical history or photographs.
All UK prescriptions are dispensed by registered pharmacies.
The standard NHS prescription charge in England is 9.90 pounds per item; prescriptions are free in Scotland, Wales, and Northern Ireland.
Bettamousse compared with other scalp treatments
Several potent corticosteroid scalp preparations are available in the UK, including betamethasone valerate 0.1% scalp application (liquid), betamethasone dipropionate with calcipotriol scalp gel (Enstilar), and clobetasol propionate 0.05% scalp application (Dermovate Scalp Application, which is very potent).
Bettamousse offers the advantage of a non-greasy foam vehicle that is preferred by many patients for daily use, as it dries quickly and does not leave visible residue in the hair.
For maintenance after a potent corticosteroid course, options include calcipotriol scalp solution, coal tar shampoo, ketoconazole 2% shampoo (for seborrhoeic dermatitis), and salicylic acid preparations for descaling thickened plaques before applying active treatments.
Living with scalp psoriasis and seborrhoeic dermatitis
Scalp conditions can have a significant psychological impact due to visible flaking, scaling, and the need for ongoing management.
Practical measures can complement pharmacological treatment: use gentle, fragrance-free shampoos when not using medicated products, avoid excessive heat styling, and resist the temptation to pick or scratch plaques, which can worsen inflammation and cause hair breakage.
Support is available through the Psoriasis Association, the National Eczema Society, and NHS psychological services for those affected by the emotional burden of visible skin disease.
When to seek urgent medical advice
Contact your GP or NHS 111 if your scalp condition deteriorates rapidly, if you develop painful, spreading scalp infection, or if you experience significant hair loss.
Seek emergency care by calling 999 or attending A&E if you develop signs of anaphylaxis or a severe allergic reaction.
Sources
- Bettamousse, Summary of Product Characteristics (EMC)
- Betamethasone, British National Formulary (BNF)
- NICE CG153: Psoriasis, assessment and management
- Psoriasis, NHS
- MHRA Yellow Card Scheme
Compare similar medicines
Anusol HC Anusol HC contains hydrocortisone acetate 10mg with bismuth subgallate, bismuth oxide, balsam Peru and zinc oxide for the relief of internal and external haemorrhoids, pr Betamethasone Betamethasone is a potent topical corticosteroid used to treat inflammatory skin conditions including eczema, psoriasis, and dermatitis.
It works by suppressing the immun Betnovate Betnovate contains betamethasone valerate 0.1%, a potent topical corticosteroid manufactured by GlaxoSmithKline.
It is prescribed for the treatment of inflammatory skin c Clobetasone Butyrate Clobetasone butyrate is a moderately potent topical corticosteroid used in the United Kingdom for the short-term treatment of eczema, dermatitis, and other steroid-respon Daktacort Daktacort cream contains hydrocortisone 1% and miconazole nitrate 2%, combining a mild corticosteroid with a broad-spectrum antifungal agent.
It is indicated for the trea Dermovate Dermovate contains clobetasol propionate 0.05%, a very potent (Class I) topical corticosteroid used for the short-term treatment of severe, resistant inflammatory skin co Dermovate-NN Dermovate-NN contains clobetasol propionate 0.05%, neomycin sulphate 0.5%, and nystatin 100,000 units per gram, combining a very potent (Class I) topical corticosteroid w Diprosalic Diprosalic contains betamethasone dipropionate 0.05% and salicylic acid 3%, combining a potent topical corticosteroid with a keratolytic agent.
It is licensed in the Unit